The primary efficacy outcome , survival at @ months after cardiac arrest with a Vineland Adaptive Behavior Scales , second edition ( VABS-II ) , score of @ or higher ( on a scale from @ to @ , with higher scores indicating better function ) , was evaluated among patients with a VABS-II score of at least @ before cardiac arrest .